Drugs to Lower Cancer Risk
Learn about laws and legal protections that impact the hereditary cancer community. Learn how to file a grievance or complaint.

Stay up to date on research and information

Sign Up for FORCE Newsletters

Privacy, Policy & Legal Issues > Laws & Protections > ACA > Screening & Preventive Services

Medication to lower cancer risk for certain women

The Patient Protection and Affordable Care Act (ACA) requires most health insurance plans to pay for “chemoprevention counseling” and if appropriate, medications that reduce a woman's risk of cancer such as tamoxifen or raloxifene, or aromatase inhibitors. These medications must be covered at 100%, with no out-of-pocket costs for women ages 35 and older who meet the U.S. Preventive Services Task Force (USPSTF) guidelines. However, the law does not apply to women under the age of 35 and some high-risk women may not be eligible for 100% coverage.

Note that the ACA does not apply to Medicare or Medicaid. They have their own rules. See the Insurance & Reimbursement section of our website to learn more.

Paying For Care
Paying For Care

 

  • Problems with insurance coverage of medications or other recommended screening and preventive services? Visit our section on Insurance & Reimbursement for guidance.

 

Open Clinical Trials
Open Clinical Trials


  • Visit the FORCE Research Study Search tool for information on hereditary cancer prevention and early detection research studies.